Gene · 2160
Papers2,705
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,705
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Proteome-wide mendelian randomization identifies causal plasma proteins in venous thromboembolism development. | J Hum Genet | 2023 | 37537391 | PubTator, text mining | PubMed |
| Genotype Hemophilia Screening Program Identified 2 Novel Variants Including a Novel Variant (c.5816-2A > G) Causing a Pathogenic Variant of the Factor 8 Gene. | Clin Appl Thromb Hemost | 2023 | 37525882 | PubTator, text mining | PubMed |
| An Overview of the Development and Preclinical Evaluation of Antibody-Drug Conjugates for Non-Oncological Applications. | Pharmaceutics | 2023 | 37513995 | PubTator, text mining | PubMed |
| Hemostatic Effects of Raloxifene in Ovariectomized Rats. | Life (Basel) | 2023 | 37511987 | PubTator, text mining | PubMed |
| Integrative Plasma Metabolic and Lipidomic Modelling of SARS-CoV-2 Infection in Relation to Clinical Severity and Early Mortality Prediction. | Int J Mol Sci | 2023 | 37511373 | PubTator, text mining | PubMed |
| Editorial: Insights in thrombosis: 2022. | Front Cardiovasc Med | 2023 | 37485270 | PubTator, text mining | PubMed |
| Non-coding RNA therapeutics in cardiovascular diseases and risk factors: Systematic review. | Noncoding RNA Res | 2023 | 37483458 | PubTator, text mining | PubMed |
| Minimal RNA self-reproduction discovered from a random pool of oligomers. | Chem Sci | 2023 | 37476714 | PubTator, text mining | PubMed |
| Guianensin, a Simulium guianense salivary protein, has broad anti-hemostatic and anti-inflammatory properties. | Front Immunol | 2023 | 37469515 | Swiss-Prot, curated | PubMed |
| Elevated plasma factor XI predicts cardiovascular events in patients with type 2 diabetes: a long-term observational study. | Cardiovasc Diabetol | 2023 | 37460982 | PubTator, text mining | PubMed |
| Vascular risk factors for COVID-19 ARDS: endothelium, contact-kinin system. | Front Med (Lausanne) | 2023 | 37448794 | PubTator, text mining | PubMed |
| Hemostasis Strategies and Recent Advances in Nanomaterials for Hemostasis. | Molecules | 2023 | 37446923 | PubTator, text mining | PubMed |
| Concomitant hypofibrinogenemia and factor XI deficiency as rare cause of bleeding during urgent dentistry: case report and short review of the literature. | Arch Clin Cases | 2023 | 37405328 | PubTator, text mining | PubMed |
| Pan-precancer and cancer DNA methylation profiles revealed significant tissue specificity of interrupted biological processes in tumorigenesis. | Epigenetics | 2023 | 37393582 | PubTator, text mining | PubMed |
| Clot Waveform Analysis for Hemostatic Abnormalities. | Ann Lab Med | 2023 | 37387486 | PubTator, text mining | PubMed |
| Factor XIa Inhibitors as a Novel Anticoagulation Target: Recent Clinical Research Advances. | Pharmaceuticals (Basel) | 2023 | 37375813 | PubTator, text mining | PubMed |
| Isolated Prolongation of Activated Partial Thromboplastin Time: Not Just Bleeding Risk! | Medicina (Kaunas) | 2023 | 37374373 | PubTator, text mining | PubMed |
| Acute Myocardial Infarction in Patients with Hereditary Thrombophilia-A Focus on Factor V Leiden and Prothrombin G20210A. | Life (Basel) | 2023 | 37374153 | PubTator, text mining | PubMed |
| Clotting Factor Deficiencies as an Underlying Cause of Abnormal Uterine Bleeding in Women of Reproductive Age: A Literature Review. | Life (Basel) | 2023 | 37374104 | PubTator, text mining | PubMed |
| New Insights into Antithrombotic Therapy for Cardio- and Cerebrovascular Disease: From Molecular Mechanisms to Clinical Application. | J Cardiovasc Dev Dis | 2023 | 37367423 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2160/papers?page=20